Vaxart, Inc. (VXRT) Financial Statements (2026 and earlier)

Company Profile

Business Address 170 HARBOR WAY, SUITE 300
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:51,70039,70095,70022,742126,87013,526
Cash and cash equivalent  34,75544,013 126,87013,526
Short-term investments26,4944,95849,70422,742  
Other undisclosed cash, cash equivalents, and short-term investments25,206(13)1,983   
Receivables11,9693,00820713343,619
Prepaid expense2,252     
Contract with customer, asset, after allowance for credit loss      181
Other current assets318     
Other undisclosed current assets2,0212,8283,731146,3541,327272
Total current assets:68,26045,53699,451169,167128,53117,598
Noncurrent Assets
Operating lease, right-of-use asset20,40424,84025,71513,1686,8381,990
Property, plant and equipment8,70511,73115,5856,6011,480210
Long-term investments and receivables    16,210  
Long-term investments    16,210  
Intangible assets, net (including goodwill)8,0658,7979,52815,13215,36117,093
Goodwill4,5084,5084,5084,508  
Intangible assets, net (excluding goodwill)3,5574,2895,02010,62415,36117,093
Prepaid expense60,116     
Other noncurrent assets8399263,568890372141
Total noncurrent assets:98,12946,29454,39652,00124,05119,434
TOTAL ASSETS:166,38991,830153,847221,168152,58237,032
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities18,3417,21813,5988,9366,9325,417
Accounts payable6,9631,5845,5143,8722,133852
Accrued liabilities11,3785,6348,0845,0644,7994,565
Deferred revenue   2,000   
Debt      841
Other undisclosed current liabilities72,5376,5062,3231,8474,8312,916
Total current liabilities:90,87813,72417,92110,78311,7639,174
Noncurrent Liabilities
Long-term debt and lease obligation:    11,9975,1561,472
Liabilities, other than long-term debt14,88817,67819,70817110918
Other liabilities43929323117110918
Operating lease, liability14,44917,38519,47711,9975,1561,472
Other undisclosed noncurrent liabilities1,6982,6235,62110,68612,15013,416
Total noncurrent liabilities:16,58620,30125,32922,85417,41514,906
Total liabilities:107,46434,02543,25033,63729,17824,080
Equity
Equity, attributable to parent58,92557,805110,597187,531123,40412,952
Common stock23151313114,825
Treasury stock, value(350)(366)    
Additional paid in capital535,770467,731437,992406,943272,274124,788
Accumulated other comprehensive income (loss)4(1)(299)(74)  
Accumulated deficit(476,522)(409,574)(327,109)(219,351)(148,881)(116,661)
Total equity:58,92557,805110,597187,531123,40412,952
TOTAL LIABILITIES AND EQUITY:166,38991,830153,847221,168152,58237,032

Income Statement (P&L) ($ in thousands)

9/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues28,7007,3791078924,0469,862
Gross profit:28,7007,3791078924,0469,862
Operating expenses(94,993)(90,726)(114,694)(73,644)(34,216)(25,647)
Operating loss:(66,293)(83,347)(114,587)(72,752)(30,170)(15,785)
Nonoperating income (expense)31(62)(6)(1)(13)(2,370)
Loss, foreign currency transaction, before tax  (62)(6)(1)(13)(32)
Other nonoperating income (expense)31     
Interest and debt expense      (100)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes     (1,799)100
Loss from continuing operations before equity method investments, income taxes:(66,262)(83,409)(114,593)(72,753)(31,982)(18,155)
Other undisclosed income (loss) from continuing operations before income taxes(426)1,2056,9022,390  
Loss from continuing operations before income taxes:(66,688)(82,204)(107,691)(70,363)(31,982)(18,155)
Income tax expense(260)(261)(67)(107)(238)(490)
Loss from continuing operations:(66,948)(82,465)(107,758)(70,470)(32,220)(18,645)
Loss before gain (loss) on sale of properties:(70,470)(32,220)(18,645)
Net loss available to common stockholders, diluted:(66,948)(82,465)(107,758)(70,470)(32,220)(18,645)

Comprehensive Income ($ in thousands)

9/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(66,948)(82,465)(107,758)(70,470)(32,220)(18,645)
Comprehensive loss:(66,948)(82,465)(107,758)(70,470)(32,220)(18,645)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent5298(225)(74)  
Comprehensive loss, net of tax, attributable to parent:(66,943)(82,167)(107,983)(70,544)(32,220)(18,645)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: